Oncology
Bruce Johnson, MD
Professor Emeritus of Medicine, Harvard Medical School; Institute Physician, Dana-Farber Cancer Institute
Dr. Bruce E. Johnson, MD, is a distinguished medical oncologist specializing in thoracic oncology, particularly lung cancer, at the Dana-Farber Cancer Institute in Boston, MA. With over 45 years of experience, he has focused on the molecular basis of lung cancers and the development of targeted therapies for patients with specific genomic alterations. He is one of the key investigators who discovered epidermal growth factor receptor (EGFR) mutations, revolutionizing lung cancer treatment worldwi
45+
Years in Practice
Credentials
Board Certifications
- Medical Oncology (ABMS)
Education & Training
- University of Minnesota — M.D., 1979
- University of Chicago — Residency, Internal Medicine
- National Cancer Institute — Fellowship, Medical Oncology
Peer Recognition
- ASCO — Fellow (FASCO)
2012
- ASCO Cancer Foundation — Translational Research Professorship
2008
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Dana-Farber Cancer Institute
- Brigham and Women's Hospital
Languages
English
Experience
45+ years in practice